Molecular followup of newly diagnosed bladder cancer using urine samples.

[1]  C. Cox,et al.  Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence. , 1999, The Journal of urology.

[2]  M. O'Donnell,et al.  BCG immunotherapy of bladder cancer: 20 years on , 1999, The Lancet.

[3]  A Hofstetter,et al.  Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. , 1999, The American journal of pathology.

[4]  W. C. Groat,et al.  Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. , 1998, The Journal of urology.

[5]  T. Sekiya,et al.  Allelic loss on chromosome 9 in bladder cancer tissues and urine samples detected by blunt‐end single‐strand DNA conformation polymorphism , 1998, International journal of cancer.

[6]  M. Satoh,et al.  Preselected Biopsy for Normal-Appearing Mucosa of Superficial Bladder Carcinoma , 1998, European Urology.

[7]  K. Yamaguchi,et al.  Diagnosis of bladder cancer by analysis of the allelic loss of the p53 gene in urine samples using blunt‐end single‐strand conformation polymorphism , 1997 .

[8]  H. Herr.  High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor. , 1997, Seminars in urologic oncology.

[9]  K. Yamaguchi,et al.  Correlation of Allelic Loss of the P53 Gene and Tumor Grade, Stage, and Malignant Progression in Bladder Cancer , 1997, International journal of urology : official journal of the Japanese Urological Association.

[10]  T. Sekiya,et al.  Sensitive detection of loss of heterozygosity in the TP53 gene in pancreatic adenocarcinoma by fluorescence‐based single‐strand conformation polymorphism analysis using blunt‐end DNA fragments , 1996, Genes, chromosomes & cancer.

[11]  Y S Erozan,et al.  Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis , 1996, Science.

[12]  R. Cote,et al.  Two molecular pathways to transitional cell carcinoma of the bladder. , 1994, Cancer research.

[13]  J. Cairns,et al.  Allelotype of human bladder cancer. , 1994, Cancer research.

[14]  C. Cordon-Cardo,et al.  Genetic alterations in bladder cancer , 1993, The Lancet.

[15]  T. Sugimura,et al.  Frequent association of p53 gene mutation in invasive bladder cancer. , 1992, Cancer research.

[16]  R. Sylvester,et al.  Prognostic factors in superficial bladder tumors , 1992 .

[17]  P. Scardino,et al.  A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. , 1991, The New England journal of medicine.

[18]  P. Nichols,et al.  Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. , 1990, Cancer research.

[19]  P. Abel.  Prognostic indices in transitional cell carcinoma of the bladder. , 1988, British journal of urology.

[20]  O. Dalesio,et al.  Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. , 1983, The Journal of urology.

[21]  W Lutzeyer,et al.  Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. , 1982, The Journal of urology.